TRANSIENT RECEPTOR POTENTIAL MELASTATIN 8 (TRPM8) ANTAGONISTS AND RELATED METHODS
申请人:Marshall University Research Corporation
公开号:EP3917510A1
公开(公告)日:2021-12-08
[EN] TRANSIENT RECEPTOR POTENTIAL MELASTATIN 8 (TRPM8) ANTAGONISTS AND RELATED METHODS<br/>[FR] ANTAGONISTES DU MELASTATIN POTENTIEL DE RÉCEPTEUR TRANSITOIRE 8 (TRPM8) ET MÉTHODES ASSOCIÉES
申请人:MARSHALL UNIV RESEARCH CORPORATION
公开号:WO2020160464A1
公开(公告)日:2020-08-06
A TRPM8 antagonist is provided that comprises the following the formula (I) described herein. In the formula (I), R1 is selected from a cycloalkyl, a bicycloalkyl, or a tricycloalkyl group. Each R1 group has 5 to 12 carbon atoms. Further, each R1 group is optionally substituted with an alkyl group having 1 to 5 carbons atoms or with a cycloalkyl group having 4 to 12 carbon atoms, and each R1 group is optionally saturated or partially unsaturated. Methods for treating pain are further provided and comprise administering to a subject in need thereof an effective amount of a TRPM8 antagonist comprising the formula (I).
Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies
作者:V. Blair Journigan、Zhiwei Feng、Saifur Rahman、Yuanqiang Wang、A. R. M. Ruhul Amin、Colleen E. Heffner、Nicholas Bachtel、Siyi Wang、Sara Gonzalez-Rodriguez、Asia Fernández-Carvajal、Gregorio Fernández-Ballester、Jacob K. Hilton、Wade D. Van Horn、Antonio Ferrer-Montiel、Xiang-Qun Xie、Taufiq Rahman
DOI:10.1021/acschemneuro.9b00404
日期:2020.2.5
dose-dependently blocks icilin-triggered shaking behaviors in mice. Upon local administration, compound 14 dose dependently inhibits cold allodynia evoked by the chemotherapy oxaliplatin in a murine model of peripheral neuropathy at microgram doses. Our findings suggest that 14 and other biphenyl amide analogues within our series can find utility as potent antagonist chemical probes derivedfrom (-)-menthol